QUCY — MAINZ BIOMED N.V. (Healthcare >> Diagnostics & Research)
QUCY FAQ
What is QUCY's ROE?
MAINZ BIOMED N.V. reports a Return on Equity (ROE) of -292.55%.
What is QUCY's dividend yield?
MAINZ BIOMED N.V. offers a dividend yield of 0.00%.
What is QUCY's Deepscope Quality Score?
Deepscope rates QUCY's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy QUCY?
Deepscope's AI Timing Score for QUCY is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does QUCY belong to?
MAINZ BIOMED N.V. is classified under the Healthcare >> Diagnostics & Research sector on the NASDAQ exchange.
|
USD 2.20
Price
-0.13
(-5.58%)
Day Change
|
|
|---|
QUCY, the overall quality is not good ( Quality = 38) but the timing to buy is ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
Negative growth of ROE in the last year.
Growth of ROA was below our criteria in the last year.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is ok , ...
| Quality Factors |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 97 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 2.20 |
| PBV / Sector |
12.20 / -23.44
|
| Earning Per Share | -0.53 |
| PE / Sector |
N/A / 37.86
|
| PEG or PE/Growth / Sector |
N/A / 1.41
|
| Average 1M Daily Value |
114.57 M
GREAT
|
| Average 1W Daily Value |
19.20 M
GREAT
|
| Timing Factors |
|
57% |
| Financial Health |
|
45% |
| Ability to Make Profit |
|
64% |
| Return to Investors |
|
8% |
| Registration Details |
| Analyze Date | 2026-06-06 09:09:07 |
| Symbol | QUCY |
| Name | MAINZ BIOMED N.V. |
| Sector | Healthcare >> Diagnostics & Research |
| Market | NASDAQ |
| Listed Shares | 22.77 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 56.01 / 32,142.66 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: Robert Koch Strasse 50, Mainz, Germany, 55129
Phone: 49 6131 554 2860
Website: https://quantum-cyber.ai
Description: Quantum Cyber N.V. operates as a technology company focused on cybersecurity and quantum computing solutions. The company pursues acquisitions and partnerships in areas including post-quantum cryptography, zero-trust architecture, and national security technologies. It also develops platforms that integrate artificial intelligence (AI) and quantum computing technologies for autonomous control systems used in unmanned aerial, ground, and underwater vehicles, including drones, self-driving vehicles, and robotic fleets. The company is headquartered in Mainz, Germany.
ME vs SECTOR Healthcare >> Diagnostics & Research
Click a bubble to view stock details · Bubble size represents market capitalization share
Google